Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/5/2025

Corticosteroids for Increasing Platelet Count in Immune Thrombocytopenia

First-Line Corticosteroid Options

  • The American Society of Hematology recommends prednisone 1 mg/kg/day for 21 days then tapered as the preferred first-line corticosteroid 1
  • Prednisone produces an initial response in 70-80% of patients 2
  • Longer courses of corticosteroids, such as prednisone for 21 days then tapered, are associated with a longer time to loss of response compared to shorter courses 1

Emergency/Severe Bleeding Situations

  • The American Society of Hematology recommends combining high-dose methylprednisolone with IVIG (1 g/kg) for uncontrolled bleeding or urgent procedures 3
  • High-dose methylprednisolone 30 mg/kg/day for 3-7 days achieves response rates up to 95% 2
  • Prednisone plus IVIG is recommended for emergency treatment by international consensus 3

Treatment Thresholds and Duration

  • Treatment is rarely indicated if platelet count is greater than 50 × 10⁹/L unless there is bleeding, surgery planned, or anticoagulation needed 2
  • The target platelet count is 30-50 × 10⁹/L, not normalization 2
  • It is recommended to rapidly taper and discontinue prednisone after achieving the target count 2
  • Prolonged corticosteroid courses exceeding 6-8 weeks should be avoided due to substantial morbidity 2

Common Pitfalls

  • Corticosteroids should not be continued indefinitely, as only 20-40% of patients maintain a sustained response after discontinuation, and prolonged use causes severe morbidity 2
  • Patients should be monitored for corticosteroid complications, including mood swings, weight gain, insomnia, Cushingoid features, diabetes, fluid retention, osteoporosis, hypertension, GI distress, avascular necrosis, and immunosuppression 2